title: [The concept of the development of S3 guidelines: additional benefit compared to traditional standards, problems and solutions].
abstract: Guidelines for the diagnosis and treatment of psychiatric disorders developed on the highest qualitative methodical standard cover reliable decision guidance and are an important instrument of quality improvement in health care. They have to be accessible with little effort and should be concise and clearly presented to be used in daily routine. Early integration of members of the different professions, patients and their care givers into the development process is essential for acceptance. The development process of a S3 guideline is complex and poses a difficult challenge to personal manpower and funding, which is met by the associations of the Association of Medical Societies in Germany. Further scientific discussion is necessary to find adequate solutions for problematic topics or potential distortion, such as the consequences of inadequate reporting of studies, insufficient recording and reporting of the risk of damage, unpublished data and lacking interest of sponsors in specific topics.
authors.affiliation: Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307, Dresden, Deutschland. andrea.pfennig@uniklinikum-dresden.de
authors.forename: A
authors.initials: A
authors.lastname: Pfennig
authors.forename: I
authors.initials: I
authors.lastname: Kopp
authors.forename: D
authors.initials: D
authors.lastname: Strech
authors.forename: M
authors.initials: M
authors.lastname: Bauer
mesh_terms: D005858:Germany; D006801:Humans; D001523:Mental Disorders / Q000175:diagnosis* / Q000628:therapy*; D009462:Neurology / Q000592:standards*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards*; D011570:Psychiatry / Q000592:standards*
references.citation: BMC Med Res Methodol. 2009 Nov 26;9:79
references.pmid: 19941636
references.citation: N Engl J Med. 2008 Jan 17;358(3):252-60
references.pmid: 18199864
references.citation: JAMA. 1999 Sep 15;282(11):1054-60
references.pmid: 10493204
references.citation: Z Evid Fortbild Qual Gesundhwes. 2010;104(4):284-91
references.pmid: 20701107
references.citation: Br J Clin Pharmacol. 2008 Dec;66(6):767-73
references.pmid: 18754841
references.citation: J Clin Epidemiol. 2010 May;63(5):502-12
references.pmid: 18823754
references.citation: Z Rheumatol. 2010 Jun;69(4):298-304
references.pmid: 20490515
references.citation: Ann Intern Med. 2001 Apr 17;134(8):663-94
references.pmid: 11304107
references.citation: Z Arztl Fortbild Qualitatssich. 2007;101(2):89-95
references.pmid: 17458353
references.citation: Lancet. 2009 Jul 25;374(9686):273-5
references.pmid: 19394076
references.citation: BMJ. 2004 Jun 19;328(7454):1490
references.pmid: 15205295
references.citation: Radiologe. 2008 Nov;48(11):1015-6, 1018-21
references.pmid: 18972093
references.citation: Nervenarzt. 2008 Apr;79(4):500-4
references.pmid: 18389205
references.citation: J Clin Psychopharmacol. 2007 Aug;27(4):352-6
references.pmid: 17632218
references.citation: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Jan;52(1):71-6
references.pmid: 19189157
references.citation: Qual Health Care. 1996 Mar;5(1):44-50
references.pmid: 10157272
references.citation: BMJ. 1998 Oct 31;317(7167):1181-4
references.pmid: 9794850
references.citation: PLoS Med. 2010 Mar 24;7(3):e1000251
references.pmid: 20352064